tiprankstipranks
Sunshine Biopharma (SBFM)
NASDAQ:SBFM
US Market

Sunshine Biopharma (SBFM) Income Statement

Compare
376 Followers

Sunshine Biopharma Income Statement

Last quarter (Q3 2024), Sunshine Biopharma's total revenue was $8.44M, an increase of 41.59% from the same quarter last year. In Q3, Sunshine Biopharma's net income was $-1.20M. See Sunshine Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 24.09M$ 4.35M$ 228.43K$ 71.41K$ 21.12K
Gross Profit
$ 8.34M$ 1.70M$ 110.60K$ 45.56K$ 10.07K
Operating Expenses
$ 13.12M$ 10.37M$ 2.55M$ 622.44K$ 651.71K
Depreciation and Amortization
$ 149.15K$ 25.16K$ 12.74K$ 14.07K$ 13.77K
EBITDA
$ -3.82M$ -26.45M$ -12.09M$ -2.60M$ -948.38K
Operating Income
$ -4.79M$ -8.67M$ -2.44M$ -576.87K$ -641.64K
Other Income/Expenses
$ 674.42K$ 489.61K$ -10.00M$ -2.21M$ -436.42K
Pretax Income
$ -4.11M$ -26.51M$ -12.44M$ -2.78M$ -1.08M
Net Income
$ -4.51M$ -26.74M$ -12.77M$ -897.68K$ -1.46M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -370.41$ -3.52K$ -9.77K$ -1.04K$ -828.01
Diluted EPS
$ -370.41$ -3.52K$ -9.77K$ -1.04K$ -828.01
Weighted Average Shares Outstanding
12.16K 7.59K 1.31K 866.00 1.76K
Weighted Average Shares Outstanding (Diluted)
12.16K 7.59K 1.31K 866.00 1.76K
Currency in USD

Sunshine Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis